DRIO — DarioHealth Cashflow Statement
0.000.00%
Last trade - 00:00
- $34.15m
- $25.61m
- $20.35m
- 20
- 54
- 27
- 25
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -17.7 | -29.4 | -76.8 | -62.2 | -59.4 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 2.63 | 11.4 | 26.3 | 20.1 | 20.2 |
Other Non-Cash Items | |||||
Changes in Working Capital | -0.797 | 0.15 | -3.29 | -10.5 | 3.83 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | -15.7 | -17.7 | -50.4 | -47.8 | -30.4 |
Capital Expenditures | -0.098 | -0.118 | -0.261 | -0.573 | -0.584 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -0.015 | -1.5 | -7.87 | 0 | 0.037 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.113 | -1.62 | -8.13 | -0.573 | -0.547 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 25.2 | 27.5 | 65.8 | 61.9 | 18.3 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 9.41 | 8.19 | 7.22 | 13.5 | -12.7 |